Kwamena E. Baidoo
Affiliations: | Johns Hopkins University, Baltimore, MD |
Area:
Pharmaceutical ChemistryGoogle:
"Kwamena Baidoo"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Escorcia FE, Houghton JL, Abdel-Atti D, et al. (2020) ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors. Theranostics. 10: 151-165 |
| Ray Banerjee S, Minn IL, Kumar V, et al. (2019) Preclinical evaluation of Pb-labeled low-molecular-weight compounds for targeted radiopharmaceutical therapy of prostate cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |
| Milenic DE, Kim YS, Baidoo KE, et al. (2018) Exploration of a F(ab') Fragment as the Targeting Agent of α-Radiation Therapy: A Comparison of the Therapeutic Benefit of Intraperitoneal and Intravenous Administered Radioimmunotherapy. Cancer Biotherapy & Radiopharmaceuticals. 33: 182-193 |
| Milenic DE, Baidoo KE, Kim YS, et al. (2017) Comparative studies on the therapeutic benefit of targeted α-particle radiation therapy for the treatment of disseminated intraperitoneal disease. Dalton Transactions (Cambridge, England : 2003) |
| Milenic DE, Baidoo KE, Kim YS, et al. (2017) Targeted α-Particle Radiation Therapy of HER1-Positive Disseminated Intraperitoneal Disease: An Investigation of the Human Anti-EGFR Monoclonal Antibody, Panitumumab. Translational Oncology. 10: 535-545 |
| Kiess A, Minn IL, Vaidyanathan G, et al. (2016) (2S)-2-(3-(1-Carboxy-5-(4-[211At]astatobenzamido)pentyl)ureido)-pentanedioic acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |
| Yong KJ, Milenic DE, Baidoo KE, et al. (2016) Mechanisms of Cell Killing Response from Low Linear Energy Transfer (LET) Radiation Originating from (177)Lu Radioimmunotherapy Targeting Disseminated Intraperitoneal Tumor Xenografts. International Journal of Molecular Sciences. 17 |
| Kim YS, Zhou Y, Bryant H, et al. (2015) Synthesis and characterization of gadolinium-Peptidomimetic complex as an αvβ3 integrin targeted MR contrast agent. Bioorganic & Medicinal Chemistry Letters. 25: 2056-9 |
| Banerjee SR, Foss CA, Pullambhatla M, et al. (2015) Preclinical evaluation of 86Y-labeled inhibitors of prostate-specific membrane antigen for dosimetry estimates. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 628-34 |
| Milenic DE, Baidoo KE, Kim YS, et al. (2015) Evaluation of cetuximab as a candidate for targeted α-particle radiation therapy of HER1-positive disseminated intraperitoneal disease. Mabs. 7: 255-64 |